Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial

Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial.

Novitt-Moreno A, Martidis A, Gonzalez V, Ransom J, Scott CB, Dow G, Reid M, Smith B, Zottig VE, Read LT, Garver Baldwin LS, Chen FK.

Travel Med Infect Dis. 2022 Jan-Feb;45:102211. doi: 10.1016/j.tmaid.2021.102211. Epub 2021 Nov 18.

PMID: 34801714 Free article.